Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMDW) Return on Assets (2020 - 2025)

Historic Return on Assets for Revolution Medicines (RVMDW) over the last 6 years, with Q3 2025 value amounting to 0.41%.

  • Revolution Medicines' Return on Assets fell 900.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.26% for FY2024, which is 400.0% up from last year.
  • Latest data reveals that Revolution Medicines reported Return on Assets of 0.41% as of Q3 2025, which was down 900.0% from 0.34% recorded in Q2 2025.
  • Over the past 5 years, Revolution Medicines' Return on Assets peaked at 0.18% during Q2 2021, and registered a low of 0.41% during Q3 2025.
  • In the last 5 years, Revolution Medicines' Return on Assets had a median value of 0.28% in 2025 and averaged 0.29%.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -1600bps in 2022, then surged by 700bps in 2023.
  • Over the past 5 years, Revolution Medicines' Return on Assets (Quarter) stood at 0.25% in 2021, then fell by -20bps to 0.3% in 2022, then rose by 6bps to 0.29% in 2023, then grew by 3bps to 0.28% in 2024, then crashed by -48bps to 0.41% in 2025.
  • Its Return on Assets was 0.41% in Q3 2025, compared to 0.34% in Q2 2025 and 0.28% in Q1 2025.